RETINOL BINDING PROTEIN - ANVISA Registration 80464810626
Access comprehensive regulatory information for RETINOL BINDING PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810626 and manufactured by WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including Nanosens Ltda, TRIMERO DIAGNOSTICS, S.L., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80464810626
25351402611201877
09377976000152
Company Information
Dates and Status
Feb 11, 2019
VIGENTE
09/18/2025 19:00:01
RETINOL LIGADO A PROTEÍNA
3diag - RBP - OPT Kit
TRIMERO DIAGNOSTICS, S.L.
81357320144
Mar 17, 2025
RETINOL LIGADO A PROTEÍNA
3diag – U-RBP - OPT Kit
TRIMERO DIAGNOSTICS, S.L.
81357320145
Mar 17, 2025
RETINOL LIGADO A PROTEÍNA
Proteína de Ligação ao Retinol (RBP) Alinity®
DIAGAM S.A.
81546350071
Apr 22, 2024
RETINOL LIGADO A PROTEÍNA
Proteína de Ligação ao Retinol (RBP) Architect® c4000/c8000/c16000
DIAGAM S.A.
81546350072
Apr 22, 2024
RETINOL LIGADO A PROTEÍNA
CONTROLE MÉDIO RETINOL BINDING PROTEIN (RBP)
Nanosens Ltda
81546350050
Jan 16, 2023

